165 related articles for article (PubMed ID: 11313994)
21. Isolated loss of PMS2 expression in colorectal cancers: frequency, patient age, and familial aggregation.
Gill S; Lindor NM; Burgart LJ; Smalley R; Leontovich O; French AJ; Goldberg RM; Sargent DJ; Jass JR; Hopper JL; Jenkins MA; Young J; Barker MA; Walsh MD; Ruszkiewicz AR; Thibodeau SN
Clin Cancer Res; 2005 Sep; 11(18):6466-71. PubMed ID: 16166421
[TBL] [Abstract][Full Text] [Related]
22. Frequency and types of spontaneous Hprt lymphocyte mutations in Pms2-deficient mice.
Shaddock JG; Dobrovolsky VN; Mittelstaedt RA; Heflich RH; Parsons BL
Mutat Res; 2006 Mar; 595(1-2):69-79. PubMed ID: 16336979
[TBL] [Abstract][Full Text] [Related]
23. Polymorphisms and HNPCC: PMS2-MLH1 protein interactions diminished by single nucleotide polymorphisms.
Yuan ZQ; Gottlieb B; Beitel LK; Wong N; Gordon PH; Wang Q; Puisieux A; Foulkes WD; Trifiro M
Hum Mutat; 2002 Feb; 19(2):108-13. PubMed ID: 11793469
[TBL] [Abstract][Full Text] [Related]
24. Tumor-associated Apc mutations in Mlh1-/- Apc1638N mice reveal a mutational signature of Mlh1 deficiency.
Kuraguchi M; Edelmann W; Yang K; Lipkin M; Kucherlapati R; Brown AM
Oncogene; 2000 Nov; 19(50):5755-63. PubMed ID: 11126362
[TBL] [Abstract][Full Text] [Related]
25. Hypermutability to ionizing radiation in mismatch repair-deficient, Pms2 knockout mice.
Xu XS; Narayanan L; Dunklee B; Liskay RM; Glazer PM
Cancer Res; 2001 May; 61(9):3775-80. PubMed ID: 11325851
[TBL] [Abstract][Full Text] [Related]
26. An intact Pms2 ATPase domain is not essential for male fertility.
Fischer JM; Dudley S; Miller AJ; Liskay RM
DNA Repair (Amst); 2016 Mar; 39():46-51. PubMed ID: 26753533
[TBL] [Abstract][Full Text] [Related]
27. Nuclear import of human MLH1, PMS2, and MutLalpha: redundancy is the key.
Leong V; Lorenowicz J; Kozij N; Guarné A
Mol Carcinog; 2009 Aug; 48(8):742-50. PubMed ID: 19148896
[TBL] [Abstract][Full Text] [Related]
28. Dimerization of MLH1 and PMS2 limits nuclear localization of MutLalpha.
Wu X; Platt JL; Cascalho M
Mol Cell Biol; 2003 May; 23(9):3320-8. PubMed ID: 12697830
[TBL] [Abstract][Full Text] [Related]
29. Mlh1 can function in antibody class switch recombination independently of Msh2.
Schrader CE; Vardo J; Stavnezer J
J Exp Med; 2003 May; 197(10):1377-83. PubMed ID: 12743174
[TBL] [Abstract][Full Text] [Related]
30. Elevated levels of the mismatch repair protein PMS2 are associated with prostate cancer.
Norris AM; Woodruff RD; D'Agostino RB; Clodfelter JE; Scarpinato KD
Prostate; 2007 Feb; 67(2):214-25. PubMed ID: 17044039
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms underlying mismatch repair deficiencies in normal cells.
Moliaka YK; Cella M; Chudina AP; Kolesnikova TN; Terracciano L; Cathomas G; Bochkov NP; Buerstedde JM
Genes Chromosomes Cancer; 1997 Nov; 20(3):305-9. PubMed ID: 9365839
[TBL] [Abstract][Full Text] [Related]
32. Hypermutation in Ig V genes from mice deficient in the MLH1 mismatch repair protein.
Phung QH; Winter DB; Alrefai R; Gearhart PJ
J Immunol; 1999 Mar; 162(6):3121-4. PubMed ID: 10092760
[TBL] [Abstract][Full Text] [Related]
33. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.
Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL
J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158
[TBL] [Abstract][Full Text] [Related]
34. Visualization of mosaicism in tissues of normal and mismatch-repair-deficient mice carrying a microsatellite-containing transgene.
Hersh MN; Stambrook PJ; Stringer JR
Mutat Res; 2002 Aug; 505(1-2):51-62. PubMed ID: 12175905
[TBL] [Abstract][Full Text] [Related]
35. Heterozygous DNA mismatch repair gene PMS2-knockout mice are susceptible to intestinal tumor induction with N-methyl-N-nitrosourea.
Qin X; Shibata D; Gerson SL
Carcinogenesis; 2000 Apr; 21(4):833-8. PubMed ID: 10753224
[TBL] [Abstract][Full Text] [Related]
36. Meiotic arrest and aneuploidy in MLH3-deficient mice.
Lipkin SM; Moens PB; Wang V; Lenzi M; Shanmugarajah D; Gilgeous A; Thomas J; Cheng J; Touchman JW; Green ED; Schwartzberg P; Collins FS; Cohen PE
Nat Genet; 2002 Aug; 31(4):385-90. PubMed ID: 12091911
[TBL] [Abstract][Full Text] [Related]
37. Identification of the mismatch repair genes PMS2 and MLH1 as p53 target genes by using serial analysis of binding elements.
Chen J; Sadowski I
Proc Natl Acad Sci U S A; 2005 Mar; 102(13):4813-8. PubMed ID: 15781865
[TBL] [Abstract][Full Text] [Related]
38. Microsatellite instability and expression of MLH1 and MSH2 in carcinomas of the small intestine.
Planck M; Ericson K; Piotrowska Z; Halvarsson B; Rambech E; Nilbert M
Cancer; 2003 Mar; 97(6):1551-7. PubMed ID: 12627520
[TBL] [Abstract][Full Text] [Related]
39. Loss of heterozygosity and point mutation at Aprt locus in T cells and fibroblasts of Pms2-/- mice.
Shao C; Yin M; Deng L; Stambrook PJ; Doetschman T; Tischfield JA
Oncogene; 2002 Apr; 21(18):2840-5. PubMed ID: 11973643
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of the DNA mismatch repair factor, PMS2, confers hypermutability and DNA damage tolerance.
Gibson SL; Narayanan L; Hegan DC; Buermeyer AB; Liskay RM; Glazer PM
Cancer Lett; 2006 Dec; 244(2):195-202. PubMed ID: 16426742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
